| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | VP Finance &Corp. Controller
2 companies
Vazzano Joseph Walter is a Chief Financial Officer at ABEONA THERAPEUTICS INC. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 7 sells.
Estimated insider holdings value: $3.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | ABEO Abeona Therapeutics Inc. | Chief Financial Officer | Sell | 9,035 | $5.39 | $48,730.27 | -2.0% | +0.8% | - | |
| Aug 15, 2025 | ABEO Abeona Therapeutics Inc. | Chief Financial Officer | Sell | 15,000 | $7.36 | $110,358.00 | -3.1% | -36.5% | - | |
| Jul 22, 2025 | ABEO Abeona Therapeutics Inc. | Chief Financial Officer | Sell | 1,502 | $6.64 | $9,974.63 | -0.3% | -15.6% | - | |
| Jul 9, 2025 | ABEO Abeona Therapeutics Inc. | Chief Financial Officer | Sell | 25,411 | $5.86 | $148,799.19 | -5.0% | -9.9% | - | |
| Jun 6, 2025 | ABEO Abeona Therapeutics Inc. | Chief Financial Officer | Sell | 17,795 | $6.76 | $120,294.20 | -3.5% | +1.8% | - | |
| Apr 25, 2024 | ABEO Abeona Therapeutics Inc. | Chief Financial Officer | Buy | 5,608 | $3.14 | $17,609.12 | +2.5% | +58.3% | +67.1% | |
| Sep 19, 2023 | ABEO Abeona Therapeutics Inc. | Chief Financial Officer | Buy | 3,000 | $3.82 | $11,458.32 | +0.6% | +24.0% | +43.8% | |
| Nov 18, 2022 | ABEO Abeona Therapeutics Inc. | Chief Financial Officer | Buy | 2,500 | $4.00 | $10,000.00 | +2.7% | -42.1% | +3.7% | |
| Sep 15, 2021 | ATXI Avenue Therapeutics, Inc. | Chief Financial Officer | Sell | 7,160 | $1.62 | $11,599.20 | -9.9% | - | - | |
| Aug 20, 2020 | ATXI Avenue Therapeutics, Inc. | Chief Financial Officer | Sell | 3,840 | $12.13 | $46,579.20 | -6.3% | - | - |